venlafaxine hydrochloride has been researched along with Brain Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brajcich, MR; Marks, J; Messer, RD; Murphy, ME; Palau, MA | 1 |
| Brown, R; Holland, J | 1 |
| Osterfeld, ND; Uttner, I; Wolf, RC | 1 |
1 review(s) available for venlafaxine hydrochloride and Brain Disorders
| Article | Year |
|---|---|
Neonatal venlafaxine discontinuation syndrome: A mini-review.
Topics: Antidepressive Agents; Brain Diseases; Female; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Seizures; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2017 |
2 other study(ies) available for venlafaxine hydrochloride and Brain Disorders
| Article | Year |
|---|---|
Why the Maternal Medication List Matters: Neonatal Toxicity From Combined Serotonergic Exposures.
Topics: Antidepressive Agents; Bipolar Disorder; Brain Diseases; Bupropion; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Infant, Newborn; Male; Neurotransmitter Uptake Inhibitors; Pregnancy; Pregnancy Complications; Quetiapine Fumarate; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2021 |
[Depressive symptoms in a case of "posterior cortical atrophy"].
Topics: Affect; Antidepressive Agents, Second-Generation; Atrophy; Brain Diseases; Cerebral Cortex; Cognition Disorders; Cyclohexanols; Depressive Disorder; Electroencephalography; Evoked Potentials; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Venlafaxine Hydrochloride | 2010 |